Colgate-Palmolive (India) Earnings Call Transcripts
Fiscal Year 2026
-
Oral care penetration is universal but consumption remains low, with premiumization and e-commerce driving growth. Financial performance is strong, with high margins and increased investment in premium brands and digital advertising. The company will prioritize growth over profitability, focusing on premiumization and innovation.
-
Q4 saw 9% sales growth and strong margins, with premiumization and brand investments accelerating. Full-year sales were flat, but H2 improved, and premium brands now drive a larger share. Gross margins are expected to remain stable, with balanced growth between volume and pricing.
Fiscal Year 2025
-
FY2024-25 saw 6.5% revenue growth, strong margins, and robust premiumization, despite a Q4 revenue dip and soft urban demand. Rural and premium segments outperformed, with major product launches and continued high brand investment.
Fiscal Year 2024
-
Growth continues to outpace FMCG peers, driven by strong brand equity, premiumization, and digital-led execution. The Oral Health Movement and innovation in premium products are expanding the market, while financial discipline and ESG remain central.